These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8177014)

  • 1. Endothelin receptor antagonists exhibit diminishing potency following incubation with agonist.
    Wu-Wong JR; Chiou WJ; Naugles KE; Opgenorth TJ
    Life Sci; 1994; 54(22):1727-34. PubMed ID: 8177014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin receptor agonists and antagonists exhibit different dissociation characteristics.
    Wu-Wong JR; Chiou WJ; Magnuson SR; Opgenorth TJ
    Biochim Biophys Acta; 1994 Nov; 1224(2):288-94. PubMed ID: 7981244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissociation characteristics of endothelin ETA receptor agonists and antagonists.
    Wu-Wong JR; Chiou WJ; Dixon DB; Opgenorth TJ
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S380-4. PubMed ID: 8587421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human astrocytoma U138MG cells express predominantly type-A endothelin receptor.
    Wu-Wong JR; Chiou W; Magnuson SR; Bianchi BR; Lin CW
    Biochim Biophys Acta; 1996 May; 1311(3):155-63. PubMed ID: 8664342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin receptor in human astrocytoma U373MG cells: binding, dissociation, receptor internalization.
    Wu-Wong JR; Chiou WJ; Magnuson SR; Opgenorth TJ
    J Pharmacol Exp Ther; 1995 Jul; 274(1):499-507. PubMed ID: 7616437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation characteristics of endothelin receptor agonists and antagonists in cloned human type-B endothelin receptor.
    Chiou WJ; Magnuson SR; Dixon D; Sundy S; Opgenorth TJ; Wu-Wong JR
    Endothelium; 1997; 5(3):179-89. PubMed ID: 9272381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro characterization of Ro 46-2005, a novel synthetic non-peptide endothelin antagonist of ETA and ETB receptors.
    Breu V; Löffler BM; Clozel M
    FEBS Lett; 1993 Nov; 334(2):210-4. PubMed ID: 8224248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of three non-peptide endothelin receptor ligands using human cloned ETA and ETB receptors.
    Buchan KW; Alldus C; Christodoulou C; Clark KL; Dykes CW; Sumner MJ; Wallace DM; White DG; Watts IS
    Br J Pharmacol; 1994 Aug; 112(4):1251-7. PubMed ID: 7952888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelins and endothelin receptor antagonists: binding to plasma proteins.
    Wu-Wong JR; Chiou WJ; Hoffman DJ; Winn M; von Geldern TW; Opgenorth TJ
    Life Sci; 1996; 58(21):1839-47. PubMed ID: 8637410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of a novel endothelin receptor that binds both ETA- and ETB-selective ligands.
    Nambi P; Pullen M; Kincaid J; Nuthulaganti P; Aiyar N; Brooks DP; Gellai M; Kumar C
    Mol Pharmacol; 1997 Oct; 52(4):582-9. PubMed ID: 9380020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of the rat cerebellar endothelin B (ETB) receptor using the novel agonist radioligand [125I]BQ3020.
    Jarvis MF; Assal AA; Gessner G
    Brain Res; 1994 Nov; 665(1):33-8. PubMed ID: 7882015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of endothelin A (ETA) and endothelin B (ETB) receptors in cultured bovine retinal pericytes.
    McDonald DM; Bailie JR; Archer DB; Chakravarthy U
    Invest Ophthalmol Vis Sci; 1995 May; 36(6):1088-94. PubMed ID: 7730018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of endothelin receptors in mesangial cells: evidence for two functionally distinct endothelin binding sites.
    Simonson MS; Rooney A
    Mol Pharmacol; 1994 Jul; 46(1):41-50. PubMed ID: 8058055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between guanine nucleotide effect and reversible binding property of endothelin analogs.
    Nambi P; Pullen M; Aiyar N
    Neuropeptides; 1996 Feb; 30(1):109-14. PubMed ID: 8868308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BMS-182874 is a selective, nonpeptide endothelin ETA receptor antagonist.
    Webb ML; Bird JE; Liu EC; Rose PM; Serafino R; Stein PD; Moreland S
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1124-34. PubMed ID: 7891325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin receptor antagonists: effect of serum albumin on potency and comparison of pharmacological characteristics.
    Wu-Wong JR; Dixon DB; Chiou WJ; Opgenorth TJ
    J Pharmacol Exp Ther; 1997 May; 281(2):791-8. PubMed ID: 9152387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor.
    Ihara M; Noguchi K; Saeki T; Fukuroda T; Tsuchida S; Kimura S; Fukami T; Ishikawa K; Nishikibe M; Yano M
    Life Sci; 1992; 50(4):247-55. PubMed ID: 1310132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin ETB receptors couple to two distinct signaling pathways in porcine kidney epithelial LLC-PK1 cells.
    Ozaki S; Ihara M; Saeki T; Fukami T; Ishikawa K; Yano M
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1035-40. PubMed ID: 7932150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the endothelin receptor selective agonist, BQ3020 and antagonists BQ123, FR139317, BQ788, 50235, Ro462005 and bosentan in the heart.
    Peter MG; Davenport AP
    Br J Pharmacol; 1996 Feb; 117(3):455-462. PubMed ID: 8821534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin receptors in human smooth muscle cells: antagonist potency differs on agonist-evoked responses.
    Wu-Wong JR; Chiou WJ; Huang ZJ; Vidal MJ; Opgenorth TJ
    Am J Physiol; 1994 Nov; 267(5 Pt 1):C1185-95. PubMed ID: 7977682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.